1,420
Views
19
CrossRef citations to date
0
Altmetric
Reviews

Blood biomarkers for assessment of mild traumatic brain injury and chronic traumatic encephalopathy

ORCID Icon, , , &
Pages 213-227 | Received 12 Jun 2019, Accepted 09 Feb 2020, Published online: 12 Mar 2020

References

  • Acosta, S.A., et al., 2013. Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. PLoS One, 8 (1), e53376.
  • Aderka, D., Le, J.M., and Vilcek, J., 1989. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. Journal of immunology (Baltimore, MD: 1950), 143 (11), 3517–3523.
  • Adlakha, Y., and Saini, N., 2014. Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. Molecular cancer, 13 (1), 33.
  • Akira, S., et al., 1990. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB journal: official publication of the federation of American societies for experimental biology, 4 (11), 2860–2867.
  • Al Nimer, F., et al., 2015. Comparative assessment of the prognostic value of biomarkers in traumatic brain injury reveals an independent role for serum levels of neurofilament light. PLoS One, 10 (7), e0132177.
  • Alosco, M.L., et al., 2017. Repetitive head impact exposure and later-life plasma total tau in former National football league players. Alzheimer's & dementia: diagnosis, assessment & disease monitoring, 7, 33–40.
  • Ashton, N.J., et al., 2019. Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration. Acta neuropathologica communications, 7 (1), 5.
  • Asken, B.M., et al., 2018. Diffusion tensor imaging (DTI) findings in adult civilian, military, and sport-related mild traumatic brain injury (mTBI): a systematic critical review. Brain imaging and behavior, 12 (2), 585–612.
  • Bak, M., et al., 2008. MicroRNA expression in the adult mouse central nervous system. RNA, 14 (3), 432–444.
  • Baruch, K., et al., 2013. CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging. Proceedings of the national academy of sciences, 110 (6), 2264–2269.
  • Bazarian, J.J., et al., 2018. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study. Lancet neurology., 17 (9), 782–789.
  • Bersani, F., et al., 2016. Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation. Brain, behavior, and immunity, 52, 153–160.
  • Bhomia, M., et al., 2016. A panel of serum MiRNA biomarkers for the diagnosis of severe to mild traumatic brain injury in humans. Scientific reports, 6 (1), 28148.
  • Bledsoe, B.E., et al., 2015. Glasgow coma scale scoring is often inaccurate. Prehospital and disaster medicine, 30 (1), 46–53.
  • Bogoslovsky, T., et al., 2016. Fluid biomarkers of traumatic brain injury and intended context of use. Diagnostics (diagnostics), 6 (4), 37.
  • Bogoslovsky, T., et al., 2017. Increases of plasma levels of glial fibrillary acidic protein, tau, and amyloid beta up to 90 days after traumatic brain injury. Journal of neurotrauma, 34 (1), 66–73.
  • Buki, A., and Povlishock, J.T., 2006. All roads lead to disconnection?–Traumatic axonal injury revisited. Acta neurochirurgica), 148 (2), 181–193. discussion 193–184.
  • Cabezas, I.L., Batista, A.H., and Rol, G.P., 2014. The role of glial cells in Alzheimer disease: potential therapeutic implications. Neurologia, 29 (5), 305–309.
  • Chen, M.H., et al., 2013. Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation. ASN neuro, 5 (5), e00125.
  • Cherry, J.D., et al., 2016. Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy. Acta neuropathologica communications, 4 (1), 112.
  • Cherry, J.D., et al., 2017. CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer’s disease. PLoS One, 12 (9), e0185541.
  • Csuka, E., et al., 1999. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-α, TGF-β1 and blood–brain barrier function. Journal of neuroimmunology, 101 (2), 211–221.
  • Cunningham, C., et al., 2005. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. The journal of neuroscience : the official journal of the society for neuroscience, 25 (40), 9275–9284.
  • de Kruijk, J.R., et al., 2001. S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls. Acta neurologica scandinavica, 103 (3), 175–179.
  • Devoto, C., et al., 2017. Inflammation relates to chronic behavioral and neurological symptoms in military personnel with traumatic brain injuries. Cell transplantation, 26 (7), 1169–1177.
  • Di Pietro, V., et al., 2017. MicroRNAs as novel biomarkers for the diagnosis and prognosis of mild and severe traumatic brain injury. Journal of neurotrauma, 34 (11), 1948–1956.
  • Di Pietro, V., et al., 2018. Salivary microRNAs: diagnostic markers of mild traumatic brain injury in contact-sport. Frontiers in molecular neuroscience., 11, 290.
  • Diaz-Arrastia, R., et al., 2014. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. Journal of neurotrauma, 31 (1), 19–25.
  • Esposito, G., et al., 2008. S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells. Journal of cellular and molecular medicine, 12 (3), 914–927.
  • Ezaki, Y., et al., 2006. Role of diffusion-weighted magnetic resonance imaging in diffuse axonal injury. Acta radiologica, 47 (7), 733–740.
  • Farah, R., et al., 2018. Salivary biomarkers for the diagnosis and monitoring of neurological diseases. Biomedical journal, 41 (2), 63–87.
  • Follert, P., Cremer, H., and Béclin, C., 2014. MicroRNAs in brain development and function: a matter of flexibility and stability. Frontiers in molecular neuroscience, 7, 5.
  • Gill, J., et al., 2018. Higher exosomal tau, amyloid-beta 42 and IL-10 are associated with mild TBIs and chronic symptoms in military personnel. Brain injury, 32 (10), 1277–1284.
  • Giulian, D., et al., 1988. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. The journal of neuroscience, 8 (7), 2485–2490.
  • Gong, B., and Leznik, E., 2007. The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders. Drug news & perspectives, 20 (6), 365–370.
  • Hanisch, U.K., and Kettenmann, H., 2007. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nature neuroscience, 10 (11), 1387–1394.
  • Hasselblatt, M., et al., 2004. Serum S100β increases in marathon runners reflect extracranial release rather than glial damage. Neurology, 62 (9), 1634–1636.
  • Hayakata, T., et al., 2004. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock, 22 (2), 102–107.
  • Heidari, K., et al., 2015. S100B protein as a screening tool for computed tomography findings after mild traumatic brain injury: systematic review and meta-analysis. Brain injury, 29 (10), 1146–1157.
  • Herrmann, M., 2001. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. Journal of neurology, neurosurgery & psychiatry, 70 (1), 95–100.
  • Hicks, S.D., et al., 2016. Salivary miRNA profiles identify children with autism spectrum disorder, correlate with adaptive behavior, and implicate ASD candidate genes involved in neurodevelopment. BMC pediatrics, 16 (1), 52.
  • Hicks, S.D., et al., 2018. Overlapping microRNA expression in saliva and cerebrospinal fluid accurately identifies pediatric traumatic brain injury. Journal of neurotrauma, 35 (1), 64–72.
  • Hiskens, M.I., et al., 2019. Modeling sports-related mild traumatic brain injury in animals-A systematic review. Journal of neuroscience research, 97 (10), 1194–1222.
  • Hu, Z., et al., 2012. Expression of miRNAs and their cooperative regulation of the pathophysiology in traumatic brain injury. PLoS One, 7 (6), e39357.
  • Hyder, A.A., et al., 2007. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation, 22 (5), 341–353.
  • Ignacio, C., et al., 2015. Alterations in serum microRNA in humans with alcohol use disorders impact cell proliferation and cell death pathways and predict structural and functional changes in brain. BMC neuroscience, 16 (1), 55.
  • Ignatowski, T., and Spengler, R., 1994. Tumor necrosis factor-α: presynaptic sensitivity is modified after antidepressant drug administration. Brain research, 665 (2), 293–299.
  • Jensen, C.J., Massie, A., and De Keyser, J., 2013. Immune players in the CNS: the astrocyte. Journal of neuroimmune pharmacology: the official journal of the society on neuroimmune pharmacology, 8 (4), 824–839.
  • Johnson, J.J., et al., 2018. Association of salivary microRNA changes with prolonged concussion symptoms. JAMA pediatrics, 172 (1), 65–73.
  • Karp, X., and Ambros, V., 2005. Developmental biology. encountering microRNAs in cell fate signaling. Science, 310 (5752), 1288–1289.
  • Kawata, K., et al., 2018. Acute changes in plasma total tau levels are independent of subconcussive head impacts in college football players. Journal of neurotrauma, 35 (2), 260–266.
  • Kay, A.D., et al., 2003. Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury. Journal of neurotrauma, 20 (10), 943–952.
  • Kleindienst, A., and Ross Bullock, M., 2006. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. Journal of neurotrauma, 23 (8), 1185–1200.
  • Klintworth, H., Garden, G., and Xia, Z., 2009. Rotenone and paraquat do not directly activate microglia or induce inflammatory cytokine release. Neuroscience letters, 462 (1), 1–5.
  • Kovac, A., Erickson, M.A., and Banks, W.A., 2011. Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide. Journal of neuroinflammation, 8 (1), 139.
  • Kushima, Y., Hama, T., and Hatanaka, H., 1992. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains. Neuroscience research, 13 (4), 267–280.
  • Lagerstedt, L., et al., 2017. H-FABP: a new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury. PLoS One, 12 (4), e0175572.
  • Lagerstedt, L., et al., 2018. Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury. PLoS One, 13 (2), e0193278.
  • LaRocca, D., et al., 2019. Comparison of serum and saliva miRNAs for identification and characterization of mTBI in adult mixed martial arts fighters. PLoS One, 14 (1), e0207785.
  • Laterza, O., et al., 2009. Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clinical chemistry, 55 (11), 1977–1983.
  • Latronico, M.V., Catalucci, D., and Condorelli, G., 2007. Emerging role of microRNAs in cardiovascular biology. Circulation research, 101 (12), 1225–1236.
  • Levin, H.S., and Diaz-Arrastia, R.R., 2015. Diagnosis, prognosis, and clinical management of mild traumatic brain injury. Lancet neurology., 14 (5), 506–517.
  • Loane, D.J., and Kumar, A., 2016. Microglia in the TBI brain: the good, the bad, and the dysregulated. Experimental neurology, 275 (Pt 3), 316–327.
  • Luo, L., 2002. Actin cytoskeleton regulation in neuronal morphogenesis and structural plasticity. Annual review of cell and developmental biology, 18 (1), 601–635.
  • Lynam-Lennon, N., Maher, S.G., and Reynolds, J.V., 2009. The roles of microRNA in cancer and apoptosis. Biological reviews of the Cambridge philosophical society, 84 (1), 55–71.
  • Mandelkow, E.M., and Mandelkow, E., 2012. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold spring harbor perspectives in medicine, 2 (7), a006247–a006247.
  • Mangano, E.N., and Hayley, S., 2009. Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: neuroimmune sensitization of neurodegeneration. Neurobiology of aging., 30 (9), 1361–1378.
  • Marangos, P.J., and Schmechel, D.E., 1987. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annual review of neuroscience, 10 (1), 269–295.
  • McCrea, M., et al., 2017. Role of advanced neuroimaging, fluid biomarkers and genetic testing in the assessment of sport-related concussion: a systematic review. British journal of sports medicine, 51 (12), 919–929.
  • McCrory, P., et al. 2017., Consensus statement on concussion in sport-the 5(th) international conference on concussion in sport held in Berlin, October 2016. British journal of sports medicine, 51 (11), 838–847.
  • McKee, A.C., et al., 2015. The neuropathology of chronic traumatic encephalopathy. Brain pathology, 25 (3), 350–364.
  • McKee, A.C., et al., 2016. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta neuropathologica, 131 (1), 75–86.
  • Metting, Z., et al., 2012. GFAP and S100B in the acute phase of mild traumatic brain injury. Neurology, 78 (18), 1428–1433.
  • Mez, J., et al., 2017. Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football. JAMA, 318 (4), 360–370.
  • Mitra, B., et al., 2017. Plasma micro-RNA biomarkers for diagnosis and prognosis after traumatic brain injury: a pilot study. Journal of clinical neuroscience: official journal of the neurosurgical society of Australasia, 38, 37–42.
  • Mondello, S., et al., 2012. Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury. Journal of neurotrauma, 29 (6), 1096–1104.
  • Montgomery, S.L., and Bowers, W.J., 2012. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. Journal of neuroimmune pharmacology, 7 (1), 42–59.
  • Muller, K., et al., 2007. S100B serum level predicts computed tomography findings after minor head injury. The journal of trauma: injury, infection, and critical care, 62 (6), 1452–1456.
  • Nam, J.W., et al., 2014. Global analyses of the effect of different cellular contexts on microRNA targeting. Molecular cell, 53 (6), 1031–1043.
  • Neselius, S., et al., 2012. CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma. PLoS One, 7 (4), e33606.
  • Nitta, M.E., et al., 2019. Acute elevation of serum inflammatory markers predicts symptom recovery after concussion. Neurology, 93 (5), e497–e507.
  • Oliver, J.M., et al., 2016. Serum neurofilament light in American football athletes over the course of a season. Journal of neurotrauma, 33 (19), 1784–1789.
  • Oliver, J.M., et al., 2017. A season of American football is not associated with changes in plasma tau. Journal of neurotrauma, 34 (23), 3295–3300.
  • Olivera, A., et al., 2015. Peripheral total tau in military personnel who sustain traumatic brain injuries during deployment. JAMA neurology, 72 (10), 1109–1116.
  • Papa, L., et al., 2012. Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Annals of emergency medicine, 59 (6), 471–483.
  • Papa, L., et al., 2012. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. The journal of trauma and acute care surgery, 72 (5), 1335–1344.
  • Papa, L., et al., 2014. GFAP out-performs S100beta in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions. Journal of neurotrauma, 31 (22), 1815–1822.
  • Papa, L., et al., 2016. Time course and diagnostic accuracy of glial and neuronal blood Biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain Injury. JAMA neurology, 73 (5), 551–560.
  • Parajuli, B., et al., 2015. CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia. Glia, 63 (12), 2274–2284.
  • Park, E., Bell, J.D., and Baker, A.J., 2008. Traumatic brain injury: can the consequences be stopped? Cmaj: Canadian medical association journal = journal de l'association medicale canadienne, 178 (9), 1163–1170.
  • Parkin, G.M., et al., 2019. Plasma tumor necrosis factor alpha is a predictor of persisting symptoms post-concussion in children. Journal of neurotrauma, 36 (11), 1768–1775.
  • Pasinetti, G.M., et al., 2012. Select non-coding RNA in blood components provide novel clinically accessible biological surrogates for improved identification of traumatic brain injury in OEF/OIF Veterans. American journal of neurodegenerative disease, 1 (1), 88–98.
  • Pellman, E.J., et al., 2003. Concussion in professional football: reconstruction of game impacts and injuries. Neurosurgery, 53 (4), 799–812. discussion 812–794.
  • Posti, J.P., et al., 2017. Glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 are not specific biomarkers for mild CT-negative traumatic brain injury. Journal of neurotrauma, 34 (7), 1427–1438.
  • Poulain, F.E., and Sobel, A., 2010. The microtubule network and neuronal morphogenesis: dynamic and coordinated orchestration through multiple players. Molecular and cellular neuroscience., 43 (1), 15–32.
  • Povlishock, J.T., and Katz, D.I., 2005. Update of neuropathology and neurological recovery after traumatic brain injury. Journal of head trauma rehabilitation, 20 (1), 76–94.
  • Putukian, M., 2017. Clinical evaluation of the concussed athlete: a view from the sideline. Journal of athletic training, 52 (3), 236–244.
  • Puvenna, V., et al., 2014. Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hits. PLoS One., 9 (5), e96296.
  • Redell, J.B., Liu, Y., and Dash, P.K., 2009. Traumatic brain injury alters expression of hippocampal microRNAs: potential regulators of multiple pathophysiological processes. Journal of neuroscience research, 87 (6), 1435–1448.
  • Redell, J.B., et al., 2010. Human traumatic brain injury alters plasma microRNA levels. Journal of neurotrauma, 27 (12), 2147–2156.
  • Robb, M.A., McInnes, P.M., and Califf, R.M., 2016. Biomarkers and surrogate endpoints: developing common terminology and definitions. JAMA, 315 (11), 1107–1108.
  • Rooker, S., et al., 2006. Spatiotemporal pattern of neuroinflammation after impact-acceleration closed head injury in the rat. Mediators of inflammation, 2006 (1), 1–6.
  • Rothaug, M., Becker-Pauly, C., and Rose-John, S., 2016. The role of interleukin-6 signaling in nervous tissue. Biochimica et biophysica acta, 1863 (6 Pt A), 1218–1227.
  • Rott, O., et al., 1993. Interleukin-6 production in “normal” and HTLV-1 tax-expressing brain-specific endothelial cells. European journal of immunology, 23 (8), 1987–1991.
  • Rubin, L.H., et al., 2019. NFL blood levels are moderated by subconcussive impacts in a cohort of college football players. Brain injury, 33 (4), 456–462.
  • Salat, D.H., et al., 2017. Neuroimaging of deployment-associated traumatic brain injury (TBI) with a focus on mild TBI (mTBI) since 2009. Brain injury, 31 (9), 1204–1219.
  • Salter, M.W., and Beggs, S., 2014. Sublime microglia: expanding roles for the guardians of the CNS. Cell, 158 (1), 15–24.
  • Sandhir, R., Onyszchuk, G., and Berman, N.E., 2008. Exacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury. Experimental neurology, 213 (2), 372–380.
  • Sawada, M., et al., 1989. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain research., 491 (2), 394–397.
  • Schmidt, O.I., et al., 2004. Tumor necrosis factor-mediated inhibition of interleukin-18 in the brain: a clinical and experimental study in head-injured patients and in a murine model of closed head injury. Journal of neuroinflammation, 1 (1), 13.
  • Shah, K., and Lahiri, D.K., 2017. A tale of the good and bad: remodeling of the microtubule network in the brain by Cdk5. Molecular neurobiology, 54 (3), 2255–2268.
  • Shahim, P., et al., 2014. Blood biomarkers for brain injury in concussed professional ice hockey players. JAMA neurology, 71 (6), 684–692.
  • Shahim, P., et al., 2017. Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports. Neurology, 88 (19), 1788–1794.
  • Smits, M., et al., 2008. Outcome after complicated minor head injury. AJNR. American journal of neuroradiology, 29 (3), 506–513.
  • Sofroniew, M.V., and Vinters, H.V., 2010. Astrocytes: biology and pathology. Acta neuropathologica, 119 (1), 7–35.
  • Stern, R.A., et al., 2011. Long-term consequences of repetitive brain trauma: chronic traumatic encephalopathy. PM&R, 3 (10 Suppl 2), S460–S467.
  • Stern, R.A., et al., 2016. Preliminary study of plasma exosomal tau as a potential biomarker for chronic traumatic encephalopathy. Journal of alzheimer's disease, 51 (4), 1099–1109.
  • Strathmann, F.G., et al., 2014. Blood-based biomarkers for traumatic brain injury: evaluation of research approaches, available methods and potential utility from the clinician and clinical laboratory perspectives. Clinical biochemistry., 47 (10–11), 876–888.
  • Teasdale, G., and Jennett, B., 1974. Assessment of coma and impaired consciousness. A practical scale. Lancet (London, England), 2 (7872), 81–84.
  • Teunissen, C.E., and Khalil, M., 2012. Neurofilaments as biomarkers in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 18 (5), 552–556.
  • Tongaonkar, P., et al., 2000. Evidence for an interaction between ubiquitin-conjugating enzymes and the 26S proteasome. Molecular and cellular biology, 20 (13), 4691–4698.
  • Tran, H.T., et al., 2011. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-beta accumulation and independently accelerates the development of tau abnormalities. Journal of neuroscience., 31 (26), 9513–9525.
  • Trifunović, J., et al., 2015. Pathologic patterns of interleukin 10 expression–a review. Biochemia medica, 25 (1), 36–48.
  • Unden, J., et al., 2013. Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update. BMC medicine, 11 (1), 50.
  • Unden, L., et al., 2015. Validation of the Scandinavian guidelines for initial management of minimal, mild and moderate traumatic brain injury in adults. BMC medicine, 13 (1), 292.
  • Vella, L.J., Hill, A.F., and Cheng, L., 2016. Focus on extracellular vesicles: exosomes and their role in protein trafficking and biomarker potential in Alzheimer’s and Parkinson’s disease. International journal of molecular sciences, 17 (2), 173.
  • Villeda, S.A., et al., 2011. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature, 477 (7362), 90–94.
  • Volman, V., and Ng, L.J., 2013. Computer modeling of mild axonal injury: implications for axonal signal transmission. Neural computation., 25 (10), 2646–2681.
  • Vos, P.E., et al., 2010. GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology, 75 (20), 1786–1793.
  • Wagner, J.A., 1996. Is IL-6 both a cytokine and a neurotrophic factor? The journal of experimental medicine, 183 (6), 2417–2419.
  • Wallace, C., et al., 2018. Heading in soccer increases serum neurofilament light protein and SCAT3 symptom metrics. BMJ open sport & exercise medicine, 4 (1), e000433.
  • Wallace, C., et al., 2018. No change in plasma tau and serum neurofilament light concentrations in adolescent athletes following sport-related concussion. PLoS One, 13 (10), e0206466.
  • Wang, W., Kwon, E.J., and Tsai, L.H., 2012. MicroRNAs in learning, memory, and neurological diseases. Learning & memory, 19 (9), 359–368.
  • Werhane, M.L., et al., 2017. Pathological vascular and inflammatory biomarkers of acute- and chronic-phase traumatic brain injury. Concussion, 2 (1), CNC30.
  • Woodcock, T., and Morganti-Kossmann, M.C., 2013. The role of markers of inflammation in traumatic brain injury. Frontiers in neurology, 4 (1), 18.
  • Yu, I., et al., 2010. Glial cell-mediated deterioration and repair of the nervous system after traumatic brain injury in a rat model as assessed by positron emission tomography. Journal of neurotrauma, 27 (8), 1463–1475.
  • Yu, W.H., and Fraser, P.E., 2001. S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease. The Journal of Neuroscience, 21 (7), 2240–2246.
  • Yuan, A., Rao, M.V., and Nixon, R.A., 2012. Neurofilaments at a glance. Journal of Cell Science, 125 (14), 3257–3263.
  • Zetterberg, H., and Blennow, K., 2016. Fluid biomarkers for mild traumatic brain injury and related conditions. Nature reviews neurology, 12 (10), 563–574.
  • Zetterberg, H., and Blennow, K., 2018. Chronic traumatic encephalopathy: fluid biomarkers. Handbook of clinical neurology, 158, 323–333.
  • Zetterberg, H., et al., 2006. Neurochemical aftermath of amateur boxing. Archives of neurology, 63 (9), 1277–1280.
  • Zetterberg, H., Smith, D.H., and Blennow, K., 2013. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nature reviews neurology, 9 (4), 201–210.
  • Zetterberg, H., et al., 2009. Sustained release of neuron-specific enolase to serum in amateur boxers. Brain injury, 23 (9), 723–726.
  • Zhangjie, S., et al., 2017. Circulating microRNA as novel early biomarker of concussion in elite athletes. British journal of sports medicine., 51 (11), A2–A3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.